Pioneering Microbiome Research & Innovation
Our multidisciplinary team ranges from microbiology, metagenomics, bioinformatics, disease biomarkers, food technology, clinical trials, intellectual property development and commercialisation.
For over a decade, our team has pioneered the use of microbiome with evidence-based science to tackle a myriad of diseases, including COVID-19, Colorectal cancer, autism, overweight and metabolic syndrome, eczema and mental health and are committed to offering new solutions to global health.